{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:25:56Z","timestamp":1787199956424,"version":"build-2736575974"},"reference-count":19,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RC-2026-2801401"],"award-info":[{"award-number":["RC-2026-2801401"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"award":["RC-2026-2801401"],"award-info":[{"award-number":["RC-2026-2801401"]}],"id":[{"id":"https:\/\/ror.org\/00789fa95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Endometrial carcinoma is a biologically and clinically heterogeneous neoplasm, for which molecular classification now plays a central role in determining prognosis and guiding treatment. The aim of this study was to develop and apply an in-house multi-gene NGS panel to expand the molecular characterization of endometrial tumors beyond the markers required for surrogate classification. Seventy primary endometrial carcinomas were selected and analyzed by immunohistochemistry for p53, mismatch repair proteins, ARID1A, and PTEN, and by NGS on DNA extracted from FFPE samples using a panel comprising 28 genes. Molecular classification was assigned according to the WHO algorithm into the subgroups POLE-mutated, MMR-deficient, p53-abnormal, and NSMP (No Specific Molecular Profile). Sixty-eight cases were evaluable by sequencing, and in 93% at least one pathogenic, likely pathogenic, or variant of uncertain significance was identified. The most frequent alterations involved PTEN, PIK3CA, ARID1A, and TP53. POLE-mutated tumors showed the highest mutational burden, while CTNNB1 alterations were predominantly associated with the NSMP subgroup. Overall, the proposed panel proved to be a useful tool for complementing conventional molecular classification and for highlighting additional genomic differences that may be biologically and clinically relevant.<\/jats:p>","DOI":"10.3390\/ijms27167384","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:12:11Z","timestamp":1787069531000},"page":"7384","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-4653","authenticated-orcid":false,"given":"Thais","family":"Maloberti","sequence":"first","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9944-2455","authenticated-orcid":false,"given":"Annalisa","family":"Altimari","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-6170","authenticated-orcid":false,"given":"Elisa","family":"Gruppioni","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poppi","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Sanza","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Costantino","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1475-4044","authenticated-orcid":false,"given":"Sara","family":"Coluccelli","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-238X","authenticated-orcid":false,"given":"Giulia","family":"Calafato","sequence":"additional","affiliation":[{"name":"Biobank of Research, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-3865","authenticated-orcid":false,"given":"Floriana Jessica","family":"Di Paola","sequence":"additional","affiliation":[{"name":"Biobank of Research, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8556-8756","authenticated-orcid":false,"given":"Caterina","family":"Ravaioli","sequence":"additional","affiliation":[{"name":"Pathology Unit, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Gianluca","family":"Corradini","sequence":"additional","affiliation":[{"name":"Pathology Unit, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2506-7239","authenticated-orcid":false,"given":"Marco","family":"Grillini","sequence":"additional","affiliation":[{"name":"Pathology Unit, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"},{"name":"Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8841-6531","authenticated-orcid":false,"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"},{"name":"Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rubino","sequence":"additional","affiliation":[{"name":"Addarii Medical Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria Di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-9091","authenticated-orcid":false,"given":"Claudio","family":"Zamagni","sequence":"additional","affiliation":[{"name":"Addarii Medical Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria Di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-6682","authenticated-orcid":false,"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3761-5135","authenticated-orcid":false,"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-8817","authenticated-orcid":false,"given":"Dario","family":"de Biase","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, 40127 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/AOG.0000000000006080","article-title":"Molecular Characterization and Clinical Implications of Endometrial Cancer","volume":"146","author":"Secord","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kumari, A., Kumar, H., Harvey, S.E., Xing, D., and Li, Z. (2025). Molecular Classification of Endometrial Carcinomas: Review and Recent Updates. Cancers, 18.","DOI":"10.3390\/cancers18010051"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial Cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111453","DOI":"10.1016\/j.ejso.2026.111453","article-title":"Integrating molecular classification into endometrial cancer management","volume":"52","author":"Bogani","year":"2026","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"de Biase, D., Maloberti, T., Corradini, A.G., Rosini, F., Grillini, M., Ruscelli, M., Coluccelli, S., Altimari, A., Gruppioni, E., and Sanza, V. (2023). Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1146499"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2022.10.024","article-title":"Molecular testing for endometrial cancer: An SGO clinical practice statement","volume":"168","author":"Walsh","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rivera, D., Paudice, M., Accorsi, G., Valentino, F., Ingaliso, M., Pianezzi, A., Roggieri, P., Trevisan, L., Buzzatti, G., and Mammoliti, S. (2023). The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis. J. Clin. Med., 12.","DOI":"10.20944\/preprints202307.2092.v1"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Paratore, S., Russo, A., Blanco, G., Lanzafame, K., Giurato, E., Bartoloni, G., D\u2019Asta, M., Sapienza, M., Solarino, V., and Vinci, V. (2025). Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort Study. Cancers, 17.","DOI":"10.3390\/cancers17111806"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Guo, Y., Yan, G., Zhang, P., Liu, Y., Zhao, C., and Zeng, X. (2024). The clinical utility of next generation sequencing in endometrial cancer: Focusing on molecular subtyping and lynch syndrome. Front. Genet., 15.","DOI":"10.3389\/fgene.2024.1440971"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.ijgc.2024.100060","article-title":"A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets","volume":"35","author":"Valentine","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103710","DOI":"10.1016\/j.esmoop.2024.103710","article-title":"Identification of molecular subtypes for endometrial carcinoma using a 46-gene next-generation sequencing panel: A retrospective study on a consecutive cohort","volume":"9","author":"Guo","year":"2024","journal-title":"ESMO Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Friedman","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.34241","article-title":"One-stop molecular classification of endometrial carcinoma using comprehensive next-generation sequencing","volume":"151","author":"Li","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"De Leo, A., Ravegnini, G., Musiani, F., Maloberti, T., Visani, M., Sanza, V., Angelini, S., Perrone, A.M., De Iaco, P., and Corradini, A.G. (2022). Relevance of ARID1A Mutations in Endometrial Carcinomas. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030592"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/ijgc-2024-005916","article-title":"Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier","volume":"34","author":"Jamieson","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104716","DOI":"10.1016\/j.ebiom.2023.104716","article-title":"Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer","volume":"94","author":"Pelegrina","year":"2023","journal-title":"EBioMedicine"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"de Biase, D., Acquaviva, G., Visani, M., Sanza, V., Argento, C.M., De Leo, A., Maloberti, T., Pession, A., and Tallini, G. (2020). Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel. Diagnostics, 10.","DOI":"10.3390\/diagnostics10040250"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO Classification of Female Genital Tumors","volume":"81","author":"Hohn","year":"2021","journal-title":"Geburtshilfe Frauenheilkd."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7384\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:15:00Z","timestamp":1787199300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":19,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167384"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167384","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}